🟢 Nanobiotix is trading 10.56% up in pre-market with no confirmed catalyst

Nanobiotix is trading at $40.00, up 10.56%, with no confirmed company-news catalyst identified overnight.

• No fresh earnings release, major filing, or company announcement was identified.
• The broader market is modestly firmer, but futures gains remain below the threshold for a clear market-driven explanation.
• Recent coverage centers on earlier clinical developments and analyst commentary, including prior positive pipeline updates; the move appears driven by positioning or an unidentified catalyst.